Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is estimated that one in four Canadians has symptoms of constipation and an estimated 38% of Canadians report constipation within the previous 12 months1. According to IQVIA the total Canadian laxative and antispasmodic market (prescription and OTC) was valued at over CDN $200 million for the 12 months ending December 2018 .
Cipher anticipates several key milestones in 2019 that will continue to enhance long term value, including:
Xydalba launch in first half of 2019
DTR-001 pre-clinical results in Q2 2019
Regulatory approval for plecanatide from Health Canada in Q4 2019
Regulatory approval for A-101 from Health Canada in Q4 2019
Top line results for MOB-015 Phase 3 study in North America expected in late Q4 2019
Largest Shareholder :
John Douglas Mull, MD 9,911,265 Grandeur Peak Global Advisors LLC 1,522,200 Taylor Asset Management, Inc. (Canada) 243,100 Harold Morton Wolkin, CFA 184,134 Arthur M. Deboeck 104,300 Mark A. Beaudet 87,790 Christian Godin 39,009 Robert D. Tessarolo 37,013 Stephen L. Lemieux, CPA 25,008 Acadian Asset Management LLC 9,093